These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 11830543

  • 21. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.
    Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N.
    Nature; 2002 Jun 27; 417(6892):954-8. PubMed ID: 12087404
    [Abstract] [Full Text] [Related]

  • 22. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin.
    Hoffmann S, Masood R, Zhang Y, He S, Ryan SJ, Gill P, Hinton DR.
    Invest Ophthalmol Vis Sci; 2000 Jul 27; 41(8):2389-93. PubMed ID: 10892888
    [Abstract] [Full Text] [Related]

  • 23. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec 27; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

  • 24. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
    Philipp W, Speicher L, Humpel C.
    Invest Ophthalmol Vis Sci; 2000 Aug 27; 41(9):2514-22. PubMed ID: 10937562
    [Abstract] [Full Text] [Related]

  • 25. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G.
    J Clin Invest; 2002 Mar 27; 109(6):777-85. PubMed ID: 11901186
    [Abstract] [Full Text] [Related]

  • 26. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D, Simak R, Steiner GE, Handisurya A, Susani M, Marberger M.
    J Urol; 2000 Aug 27; 164(2):506-10. PubMed ID: 10893635
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S, Sakamoto T, Yoshikawa H, Hata Y, Kawano Y, Ishibashi T, Inomata H, Takayama K, Ueno H.
    Invest Ophthalmol Vis Sci; 2000 Aug 27; 41(9):2395-403. PubMed ID: 10937546
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
    Bellamy WT, Richter L, Frutiger Y, Grogan TM.
    Cancer Res; 1999 Feb 01; 59(3):728-33. PubMed ID: 9973224
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
    Catalano A, Romano M, Martinotti S, Procopio A.
    Oncogene; 2002 Apr 25; 21(18):2896-900. PubMed ID: 11973650
    [Abstract] [Full Text] [Related]

  • 34. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 25; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K.
    EMBO J; 2001 Mar 15; 20(6):1223-31. PubMed ID: 11250889
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct 15; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 39. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y, Opeskin K, Goad J, Williams ED.
    Cancer Res; 2006 Oct 01; 66(19):9566-75. PubMed ID: 17018613
    [Abstract] [Full Text] [Related]

  • 40. VEGF receptor signaling and endothelial function.
    Kliche S, Waltenberger J.
    IUBMB Life; 2001 Jul 01; 52(1-2):61-6. PubMed ID: 11795595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.